Pradaxa Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Anticoagulation in Patients With Venous Thromboembolism and Cancer
Conditions:   Neoplasms;   Embolism Interventions:   Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: VKA;   Drug: LMWH Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2020 Category: Research Source Type: clinical trials

A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa ® in Healthy Subjects Under Fed Condition
Condition:   Anticoagulant Interventions:   Drug: WD-1602;   Drug: Pradaxa® Sponsor:   Hong Kong WD Pharmaceutical Co., Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials

Replication of the RELY Anticoagulant Trial in Healthcare Claims Data
Condition:   Atrial Fibrillation Interventions:   Drug: Warfarin;   Drug: Dabigatran Sponsor:   Brigham and Women's Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials

A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa ® in Healthy Subjects Under Fed Condition
Condition:   Anticoagulant Interventions:   Drug: WD-1602;   Drug: Pradaxa® Sponsor:   Hong Kong WD Pharmaceutical Co., Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials